Abstract
Previous reports suggested that cinnamaldehyde (CA), the bioactive ingredient in Cinnamomum cassia, can suppress tumor growth, migratory, and invasive abilities. However, the role and molecular mechanisms of CA in GC are not completely understood. In the present study, we found that CA-induced ER stress and cell death via the PERK–CHOP axis and Ca2+ release in GC cells. Inhibition of ER stress using specific–siRNA blocked CA-induced cell death. Interestingly, CA treatment resulted in autophagic cell death by inducing Beclin-1, ATG5, and LC3B expression and by inhibiting p62 expression whereas autophagy inhibition suppressed CA-induced cell death. We showed that CA induces the inhibition of G9a and the activation of LC3B. Moreover, CA inhibited G9a binding on Beclin-1 and LC3B promoter. Overall, these results suggested that CA regulates the PERK–CHOP signaling, and G9a inhibition activates autophagic cell death via ER stress in GC cells.
Similar content being viewed by others
Introduction
Cinnamomum cassia (called Chinese cassia or Chinese cinnamon) is an evergreen tree that is widely found in southern and eastern Asia [1]. Cinnamaldehyde (CA) is one of the most important bioactive ingredients in C. cassia and is often used as traditional Chinese medicine [2]. CA has diverse biological functions including anti-oxidant, anti-inflammation, anti-diabetic, and anti-cancer effects [3,4,5,6]. CA is a natural flavonoid, and flavonoids like luteonin, quercetin, and CA are powerful natural anti-cancer compounds that function via the inhibition of histone deacetylase (HDAC) [7,8,9]. Emerging HDAC inhibitors that induce powerful apoptosis and cell death in various cancer cell types have emerged as potent anticancer agents that can restore programmed cell death in malignant cells [10]. HDACs are upregulated in many cancer cells, and HDAC inhibition regulates cell death or growth-related genes via acetylation and methylation of histones [11]. HDAC8 has been studied to play a potential role for tumor growth and proliferation, whereas HDAC8 inhibition caused apoptosis, cell death, and cell cycle arrest in various cancer types [12].
Histone methylations via epigenetic modification on lysine 4, 9, and 27 of H3 play a potential role as cell survival or death codes and perform transcriptional activator and inhibitor activities for histone-bound genes [13]. HDAC inhibitors can frequently suppress histone methyl transferases, such as G9a and EZH2, and their inhibition regulates methylation on lysine 9 and 27 of H3 [14]. G9a is reportedly involved in cell development, cell differentiation, cell cycle, and autophagic cell death [15, 16]. G9a normally binds on LC3B promoter, but repressive binding complex with RFX5, Sin3B, and HDACs binds on LC3B promoter and blocks LC3B expression [17, 18]. Targeting HDAC regulates autophagy-related genes by inhibiting G9a [19]. BIX01294, selective inhibitor of G9a/EHMT2, could powerfully mediate autophagy and apoptosis through the mTOR/AMPK/ULK1 pathway in various cancer types, such as gastric, breast, oral squamous carcinoma, glioma, and neuroblastoma [20,21,22]. G9a inhibition may be a potential anti-cancer therapeutic strategy and a promising tumor therapeutic target.
Endoplasmic reticulum (ER) has potential function in protein translocation, folding, and maturation [23]. Disruption of ER function by diverse stimuli and pathological conditions induces ER stress by increasing misfolded or unfolded proteins [24]. Emerging reports suggested that severe or excessive ER stress causes cell death in various diseases via powerful, anticancer-related molecular mechanisms [25]. In particular, sustained intracellular calcium (Ca2+) release in ER lumen resulted in ER stress-induced cell death via Ca2+ interacting chaperones such as GRP78/Bip [26]. ER stress regulates diverse signaling pathways via the activation of three ubiquitous branches; PRKR-like ER kinase (PERK), inositol-requiring enzyme1 alpha (IRE1α), and activating transcription factor 6 (ATF6) [27]. In normal conditions, GRP78/Bip binds to unfolded protein response (UPR) such as PERK and IRE1α and inhibits ER stress signaling. However, under ER stress, GRP78 dissociates with UPR sensors [28]. With PERK release by ER stress, PERK phosphorylates eukaryotic translation initiation factor-2α (eIF2α), and its phosphorylation stimulates the activation of activating transcription factor-4 (ATF4) in the cytosol and –CCAAT-/enhancer-binding protein homologous protein (CHOP) in the nucleus [29]. Activated IRE1 regulates the splicing of the stress response transcription factor X-box binding protein-1 (XBP-1), binds to c-Jun-N-terminal inhibitory kinase (JNK) and recruits CHOP and TRAF2, which modulates the induction of ER stress-mediated cell death mechanism [30]. Recent reports on the relationship between ER stress and autophagy suggested autophagic cell death as the underlying mechanism of ER stress-induced cell death [31]. During ER stress, activated PERK mediates the phosphorylation of eIF2α and activation of ATF4, and cytosol ATF4 binds the LC3B promoter and activates autophagic cell death-related mechanism by upregulating LC3B, an autophagy-related gene [32, 33]. Furthermore, various flavonoids were recently reported to have anti-cancer effects via ER stress and autophagy [34]. However, the mechanisms by which CA induces ER stress and autophagic cell death in cancer are not well understood.
Autophagy plays a potential role in the self-cleaning process involving degradation and recycling of cellular components [35]. In cancer, autophagy has paradoxical roles, such as tumor inhibition and tumor survival [36]. Several studies have proposed that PERK-mediated ATF4 activation regulates autophagy-related genes, including Beclin-1, LC3-II, and p62, and ATF4 inhibition downregulates Beclin-1 and LC3-II and upregulates p62 [37]. Both Bcl2 and Beclin-1 are central regulators in autophagic cell death, and Bcl-2 overexpression inhibits Beclin-1-related autophagy [38]. Previous reports have studied that ER stress-induced eIF2α/ATF4 axis induces AMP-activated protein kinase (AMPK) phosphorylation leading to autophagy and cell death [39]. Furthermore, PERK–eIF2α–CHOP-dependent signaling pathway leads to transcriptional induction of LC3B and ATG5 for autophagosome formation of the autophagy process [40]. However, the mechanisms by which CA induces cell death are not well understood.
In the present study, we sought to test whether CA induces autophagic cell death via ER stress and histone change in GC. We identified that CA mediates autophagic cell death via the PERK–eIF2α–ATF4–CHOP axis and HDAC/G9a pathway in GC, thus broadening our understanding of CA as a novel anti-tumor compound.
Materials and methods
Reagents
Cinnamaldehyde (CA; W228613), cisplatin (1134357), paclitaxel (T7191), (Z-VAD-FMK; caspase inhibitor; V116), 3-methyladenine (3-MA; autophagy inhibitor; M9281), chloroquine (CQ; autophagy inhibitor; C6628), compound C (AMPK inhibitor; P5499), SBI-0206965 (ULK1 inhibitor; SML1540), BIX-01294 (G9a inhibitor; B9311), and thapsigargin (TG; ER stress inducer; T9033) were purchased from Sigma-Aldrich (St. Louis, MO USA).
Cell culture
The human GC cell lines (SNU-638, SNU-216, AGS, NCI-N87, MKN-45, and MKN-74) were purchased from the Korean Cell Line Bank (Cancer Research Center, Seoul National University, Seoul, Korea). Cells were cultured in RPMI-1640 medium (Welgene) supplemented with 10% fetal bovine serum (JR Scientific) and 100 μg/mL antibiotics (100 U/ mL penicillin and 100 μg/ mL streptomycin, Welgene) in a 5% CO2 humidified incubator at 37 °C.
Cell viability assay
The WST-1 assay was performed according to the manufacturer’s instructions (Roche, Mannheim, Germany; 11644807001) with 10 μL of WST-1 reagent added to each well of a 96-well plate (1 × 104 cell/well). To determine the cell viability in the supernatant, the conversion of WST-1 reagent into chromogenic formazan was measured and analyzed with a microplate reader (Molecular devices, USA).
LDH assay
Cells (1 × 104 cells/well) were seeded into a 96-well plate with RPMI-1640 growth medium. To determine the LDH (Thermo Scientific Pierce; 13464269) activity in supernatants, 100 μL of the reaction mixture was added and incubated for 30 min in a dark room at room temperature. The LDH activity was measured by the absorbance of the samples at 490 or 492 nm using a microplate reader (Molecular Devices, USA).
Transfection
NCI-N87 and MKN-74 cells (3 × 105 cell/well) were transfected with double-stranded siRNAs (30 nmol/mL) of LC3B (Santacruz; sc-43390), ATG5 (Santacruz; sc-41445), PERK (Santacruz; sc-36213), G9a (Santacruz; sc-43777), and CHOP (Bioneer; 1649-1) in a six-well plate for 24 h by the Lipofectamine 2000 (Invitrogen; 11668019) method according to the manufacturer’s protocol and were then recovered in RPMI-1640 medium (Welgene) containing 5% fetal bovine serum (Gibco) and 100 μg/mL antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin, Gibco) for 24 h. After recovering, viable cells were measured and analyzed using the WST-1 assay.
Isolation of protein
Protein cell lysates from cells (2 × 106 cell/well) in a 100-mm cell culture dish were collected in RIPA buffer containing a protease inhibitor cocktail (Sigma; P8340) on ice for 30 min. And then Protein cell lysates were passed through an 18-gauge needle and spun down. The supernatant was analyzed for protein content using the BCA method (Thermo scientific, Pierce BCA Protein Assay Kit, USA; 23225).
Western analysis
For Western blotting analyses, cells were solubilized in radioimmunoprecipitation assay (RIPA) lysis buffer [50-mM Tris-HCl (pH 7.4), 150-mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 1-mM phenylmethylsulfonylfluoride (PMSF), 1-mM sodium orthovanadate, and 1× Sigma protease inhibitor cocktail], and protein content was measured using a standard bicinchoninic acid assay. Equal amounts of protein (20 μg) were size-fractionated by 8%–15% SDS-PAGE and then transferred onto a PVDF membrane (Millipore Corporation, Billerica, MA, USA; IPVH00010). Membranes were blocked by incubation for 30 min with 5% skim milk/PBS-T [PBS with 5% powdered milk (BD) and 1% Tween20 (Sigma; P9416)], and incubated overnight at 4 °C with primary antibodies diluted in 1× PBST buffer. The following primary antibodies were used: β-actin (sc-47778), Bcl-2 (sc-7382), Beclin-1 (sc-48341), ULK1 (sc-390904), GRP78 (sc-166490), eIF2α (sc-133132), and ATG5 (sc-133158) (Santa Cruz, 1:1000); LC3B (Sigma, 1:1000; L7543); p62 (Sigma, 1:1000; P0068); G9a (Abcam, 1:1000; ab40542); and cleaved caspase-3 (#9654), cleaved caspase-9 (#9505), p-AMPKα (Thr172; #50082), AMPKα (#2793), p-mTOR (Ser2448; #5536), mTOR (#2983), p-ULK1 (Ser555; #5869), PERK (#5683), p-PERK (Thr980; #3170), p-eIF2α (Ser51; #3398), and CHOP (#2895)(CellSignaling, 1:1000). The membranes were washed three times with PBST buffer. A secondary antibody diluted in PBST or TBST buffer was added, and incubation was done for 40 min at room temperature. The following secondary antibodies were used: anti-rabbit IgG HRP-linked antibody (KPL, 1:6000; 5450-0010) and anti-mouse IgG HRP-linked antibody (KPL, 1:6000; 5450-0011). The membranes were washed six times with PBST buffer for 1 h. The blots were visualized using Western chemiluminescent HRP substrate (Millipore; WBKLS0500).
pEGFP-LC3 puncta
NCI-N87 and MKN-74 cells (2 × 105 cells/well) in a six-well plate were transfected with pEGFP-LC3 using Lipofectamin 2000 (Invitrogen), and then treated with CA (50 μg/mL, 24 h) for 24 h. A pEGFP-LC3B puncta was observed by confocal microscopy. Confocal microscopy was performed using a ZEISS LSM5 PASCAL confocal microscope with 405 and 488-nm excitation lasers.
Immunoprecipitation (IP) assay
We extracted cell lysates from NCI-N87 and MKN-74 cells (2 × 106/well) on a 100-mm cell culture plate in an IP buffer (pH 7.5) containing 50-mM Tris-HCl, 250-mM NaCl, 5-mM EDTA, 0.5%(v/v) NP-40, and protease inhibitor cocktail (Sigma). We incubated anti-Bcl-2 (Santa Cruz) and anti-Beclin-1 (Santa Cruz) with lysate at 4 °C for 16 h. We used protein A/G plus agarose (Santa Cruz; sc-2003) to pull down immunocomplexes. We washed precipitates three times with IP buffer. We resolved the immunoprecipitated proteins with 12% SDS-PAGE and analyzed them.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using an EZ ChIP Chromatin Immunoprecipitation kit (Millipore, Billerica, MA, USA; 17371) as described in the supplier’s protocol. Briefly, the cross-linked chromatin was sonicated after cell lysis and then incubated overnight at 4 °C with antibodies against G9a (Abcam). The immunocomplex was precipitated with protein A–agarose (Millipore), and the beads were washed, sequentially treated with 10 µL of RNase A (37 °C for 30 min) and 75 µL of proteinase K (45 °C for 4 h) and then incubated at 65 °C overnight to reverse cross-link of the chromatin. The DNA was recovered by phenol–chloroform extraction and co-precipitation with glycogen and was then dissolved in 50 µL of Tris-EDTA (TE) buffer. DNA associated with the ER was amplified by PCR using 1 µL of precipitated DNA. PCR primers [5′-GAAGTGGCTATCGCCAGAGT-3′ (sense) and 5′-GCTGCTTGAAGGTCTTCTCC-3′ (antisense)] were designed to amplify the G9a binding site on the LC3B gene promoter and PCR primers [5′-CCCGTATCATACCATTCCTAG-3′ (sense) and 5′-GAAACTCGTGTCCAGTTTCAG-3′ (antisense)] were designed to amplify the G9a binding site on the Beclin-1 gene promoter. Quantitative PCR conditions were 40 cycles at 94 °C for 40 s, 60 °C for 1 min, and 72 °C for 40 s.
Measurement of intracellular Ca2+ level
Calcium release assays were performed using a Calcium Assay Kit (Colorimetric) (Abcam; ab102505) as described in the supplier’s protocol. For the calcium release experiments, NCI-N87 and MKN-74 cells (1 × 104 cells/well) were seeded and incubated into a 96-well plate with growth medium. Then, the cells were treated with CA. NCI-N87 and MKN-74 cells were washed with calcium-free buffer and then added to chromogenic reagent and calcium assay buffer for 10 min at room temperature. The fluorescence was measured and analyzed by the absorbance of the samples at 575 nm using a microplate reader (Molecular Devices, USA).
Statistical Analysis
All results were confirmed in at least three independent experiments; Student’s t-tests were used for between-groups comparisons of the means of quantitative data, and P < 0.05 was considered statistically significant.
Results
CA suppresses the growth of GC cells
To identify the cytotoxic effects of CA in GC, we performed the cell viability and LDH release using WST-1 assay and LDH assay at indicated doses. We found that CA triggers anti-proliferative effects through a dose-dependent decrease of cell viability and increase of LDH production compared with control in various GC cell types, including SNU-638, SNU-216, AGS, NCI-N87, MKN-45, and MKN-74 cells (Fig. 1a, b). In addition, it was found that the anti-proliferative effects of CA on NCI-N87 and MKN-74 cells were time-dependent and that CA mediates LDH cytotoxicity in GC cells (Fig. 1c, d). The cytotoxic effect was identified by the increase of caspase 3 and 9 cleavage and downregulation of Bcl-2 in NCI-N87 and MKN-74 cells (Fig. 1e). To evaluate whether CA-treated cytotoxicity was associated with apoptosis, we co-treated NCI-N87 and MKN-74 cells with CA and Z-VAD-FMK (50 µM), a pan-caspase inhibitor. Our results indicated that Z-VAD-FMK alone did not significantly change the cell viability and LDH release but CA induced the decrease of cell viability and increase of LDH cytotoxicity in NCI-N87 and MKN-74 cells; however, Z-VAD-FMK inhibits the effects of CA on cell viability and LDH cytotoxicity GC cells (Fig. 1f, g). Furthermore, to further identify relationship between CA and apoptosis, we performed Western blotting analyses. Z-VAD-FMK treatment inhibits caspase-3 cleavage and CA alone mediates caspase-3 cleavage in CA-induced GC cells; however, Z-VAD-FMK suppresses caspase-3 cleavage in CA-treated GC cells (Fig. 1h). These results indicated that CA causes apoptotic cell death in GC cells.
CA mediates autophagy in GC cells
To identify whether CA regulates autophagy in GC cell, we performed Western blotting analysis which would determine the expression of the autophagy-related genes, LC3B and p62. It was found that CA causes dose-dependent increase of LC3-II and decrease of p62 in NCI-N87 and MKN-74 cells (Fig. 2a). To further analyze the autophagy effects of CA in NCI-N87 and MKN-74 cells, Western blotting analysis was performed. These results showed that CA treatment powerfully downregulated the expression of p62 and upregulated the expression of ATG5, Beclin-1 and LC3-II (Fig. 2b). To confirm autophagic vacuoles by CA treatment, pEGFP–LC3 vector was transiently transfected into both NCI-N87 and MKN-74 cells. Control cells have low LC3 puncta, whereas NCI-N87 and MKN-74 cells by CA treatment have high LC3 puncta (Fig. 2c). Anti-apoptotic Bcl-2 interacts with the autophagy-related protein Beclin-1 in ER lumen, and both Bcl-2 and Beclin-1 dissociate with the initiation of the autophagy process [41]. To investigate whether Bcl-2 interacts or dissociates with Beclin-1 in CA-treated GC cells, we performed co-immunoprecipitation (Co-IP) assay in CA-treated GC cells. When we performed the Co-IP assay with Bcl-2 antibody, Bcl-2 bound with Beclin-1 in GC cells, whereas CA treatment suppressed the interaction between Bcl-2 and Beclin-1. Furthermore, in the Co-IP assay with Beclin-1 antibody using lysates from NCI-N87 and MKN-74 cells, Beclin-1–Bcl-2 interaction was also disturbed by CA treatment (Fig. 2d). Therefore, CA treatment in GC cells leads to autophagy activation via the interruption of the Bcl-2/Beclin-1 complex. To identify synergistic autophagy effects of the combination of CA with cisplatin (5 µM) or paclitaxel (50 nM) in GC cells, we evaluated cell viability, LDH release, and the expression of autophagy-related genes such as p62, ATG5, and LC3B. Consequently, compared to CA alone, both CA + cisplatin and CA + paclitaxel decreased cell viability, enhanced LDH release, and induced the autophagy process, such as the upregulation of ATG5 and LC3B and the decrease of p62 expression (Fig. 2e and f). Taken together, our findings indicate that CA + cisplatin or CA + paclitaxel treatments induce synergic autophagic cell death in GC cells.
Cinnamaldehyde modulates the autophagic flux in GC cells
We investigated whether CA-induced autophagy is regulated by autophagy inhibitors such as 3-MA (early-stage autophagy inhibitor, 5 mM) and CQ (late-stage autophagy inhibitor, 20 µM) in GC cells. Cell viability analysis and Western blot analyses were analyzed in CA (50 μg/mL, 24 h), 3-MA (5 mM, 24 h) or CQ (20 μM, 24 h)-treated NCI-N87 and MKN-74 cells, respectively. In cell viability analysis, CA induced the reduction of cell viability, 3-MA and CQ did not change it (Supplementary Fig. 1a). In Western blot analyses, both CA and CQ treatment increase LC3II expression levels, but 3-MA alone decreases the expression levels of LC3I and LC3II (Supplementary Fig. 1b). Furthermore, we treated with CA in 3-MA or CQ-treated NCI-N87 and MKN-74 cells and performed cell viability analyses, the LDH assay, and Western blotting analysis. It was found that both 3-MA and CQ induce the restoration of cell viability and the inhibition of LDH release in CA-treated GC cells (Fig. 3a, b). In Western blotting analysis, 3-MA inhibited the expression of LC3-II indicating the disturbance of autophagosome formation, whereas both CA and CQ mediated the accumulation of LC3-II, indicating the disturbance of autophagosome formation and the interruption of the fusion of autophagosomes with lysosomes (Fig. 3c). 3-MA decreased LC3B expression in CA-treated NCI-N87 and MKN-74 cells, whereas CQ exerted the accumulation of LC3-II (Fig. 3c). Our result suggested that CA modulates the autophagic flux in GC.
Autophagy knockdown inhibits CA-induced cell death in GC cells
To confirm the knockdown of autophagy-related genes, NCI-N87 and MKN-74 cells were transfected with ATG5- and LC3B-specific siRNA, respectively, and cultured with CA treatment for 24 h; then they were subjected to cell viability analyses, the LDH assay, and Western blotting analysis. The effects of CA on cell viability and LDH release were reversed in ATG5 and LC3B knockdown NCI-N87 and MKN-74 cells compared to CTL knockdown cells (Fig. 3d, e, g, h). Furthermore, the upregulation effects on ATG5 and LC3B expression by CA were inhibited in ATG5 and LC3B knockdown NCI-N87 and MKN-74 cells (Fig. 3f, i). These results indicate that targeting autophagy disturbs autophagic cell death in CA-treated NCI-N87 and MKN-74 cells.
mTOR-AMPKα-ULK1 modulates cinnamaldehyde-mediated autophagic cell death in GC cells
To investigate the hypotheses regarding CA-induced autophagic cell death, the mTOR–AMPK–ULK1 axis in CA-treated NCI-N87 and MKN-74 cells was identified using Western blotting analysis. We demonstrated that the expression of p-AMPKα and p-ULK1 was significantly enhanced in a time-dependent manner, whereas the expression p-mTOR was downregulated by CA treatment at the indicated times (Fig. 4a). We questioned if compound C regulates CA-induced autophagic cell death by interrupting AMPKα. We co-treated NCI-N87 and MKN-74 cells with compound C and CA and performed cell viability, LDH assay and Western blotting analysis. It was found that compound C inhibited the reduction of cell viability and LDH release in CA-induced NCI-N87 and MKN-74 cells (Fig. 4b). Compound C inhibited the expression of p-AMPK, ULK1, and LC3B in CA-treated NCI-N87 and MKN-74 cells (Fig. 4c). Based on these findings, it was hypothesized that targeting ULK1 using a pharmacological inhibitor and specific siRNA may regulate CA-induced autophagic cell death in GC cells. SBI-0206965, a pharmacological ULK1 kinase inhibitor, disturbs the phosphorylation of ULK1 [42]. To investigate whether the small molecule SBI-0206965 would affect autophagic cell death in CA-treated GC cells, we treated NCI-N87 and MKN-74 cells with SBI-0206965 and CA and performed cell viability analyses, the LDH assay, and Western blotting analysis. Consequently, SBI-0206965 was found to inhibit the decrease of cell viability and the production of LDH cytotoxicity in CA-mediated NCI-N87 and MKN-74 cells (Fig. 4d). Moreover, SBI-0206965 was found to interrupt LC3B expression by suppressing the phosphorylation of ULK1 in CA-treated GC cells (Fig. 4e). After ULK1 was knocked down by specific-siRNA in NCI-N87 and MKN-74 cells, GC cells were subjected to CA treatment. On performing cell viability analysis, the LDH assay, and Western blotting analysis, we found that ULK1 knockdown inhibited the reduction of cell viability and the increase of LDH cytotoxicity in CA-treated NCI-N87 and MKN-74 cells (Fig. 4f). In addition, in Western blotting analysis, ULK1 knockdown downregulated LC3-II expression by inhibiting ULK1 activity in CA-mediated NCI-N87 and MKN-74 cells (Fig. 4g). These results suggested that targeting AMPK and ULK1 regulates CA-induced autophagic cell death in GC cells.
CA induces autophagic cell death via PERK–ATF4–CHOP signaling in GC cells
Calcium (Ca2+) was restored in ER lumen and differential intracellular calcium release has a functional role in understanding biological molecular mechanisms involved in ER stress‐induced apoptosis and cell death, and the modification of Ca2+ ion concentration is a critical initiator of ER stress-related pathways such as PERK–ATF4 and IRE1α–JNK pathways [43]. To determine the changes in Ca2+ concentration in CA-treated GC cells, we performed the calcium assay in a time-dependent manner. The results indicated that CA treatment enhances fluorescent intensity meaning Ca2+ release in NCI-N87 and MKN-74 cells (Fig. 5a). These findings suggested that the increased Ca2+ release regulates CA-induced ER stress in GC cells. To further investigate whether ER stress is associated with CA-mediated cell death, we screened the PERK axis of the ER stress pathway in a time-dependent manner in CA-treated GC cells. CA induced the expression of GRP78, p-PERK, p-eIF2α, and CHOP in NCI-N87 and MKN-74 cells (Fig. 5b). To investigate the effect of CA on ER stress in GC cells, we performed cell viability analysis, the LDH assay, the calcium assay, and Western blotting analysis with ER stress inducer TG and CA treatment. When compared to CA or TG alone, TG in combination with CA induces further reduction of cell viability and the increase of LDH and Ca2+ release (Fig. 5c–e). In Western blotting analysis, both TG and CA treatments further increased the expression of p-PERK, p-eIF2α, and CHOP in NCI-N87 and MKN-74 cells compared to TG or CA alone (Fig. 5f). These results suggested that CA induces the PERK-CHOP axis-medicated cell death through calcium ion release in GC cells.
PERK inhibition suppresses CA-induced autophagic cell death in GC cells
In normal conditions, PERK, a powerful ER stress sensor, exerts a suppressive effect via the interaction with GRP78; however, the PERK–eIF2α–ATF4–CHOP axis induces by suppressing the binding with GRP78 [44]. It was hypothesized that targeting PERK by specific siRNA may modulate CA-induced ER stress-mediated cell death in GC cells. After PERK and CHOP were transfected by specific-siRNA in NCI-N87 and MKN-74 cells, CA treatment was done. When we performed cell viability analysis, the LDH assay, the Calcium assay and Western blotting analysis, PERK and CHOP knockdown were found to suppress the decrease of cell viability and the increase of LDH cytotoxicity and calcium release in CA-treated NCI-N87 and MKN-74 cells (Figs. 6a–c, e–g). With Western blotting analysis, PERK and CHOP knockdown led to decreased p-PERK, p-eIF2α, and CHOP expression by blocking PERK in CA-treated NCI-N87 and MKN-74 cells (Fig. 6d, h). These results suggested that PERK and CHOP knockdown suppresses ER stress-mediated cell death in CA-induced GC cells.
G9a inhibition regulates cinnamaldehyde-induced autophagic cell death in GC cells
Recent reports indicate that histone modification modulates autophagy flux and is associated with early and late stages, including H3K9me2 and H4K16 deacetylation [45]. The active ingredient aqueous cinnamon extract and its active ingredients, such as cinnamaldehyde, cinnamyl alcohol, and cinnamic acid, regulate HDAC activity [46]. BIX-01294, a G9-specific inhibitor, mediates the reduction of H3K9me2 via G9a inhibition and induces autophagic cell death through the AMPK axis [47]. To identify whether CA treatment regulates the G9a expression in GC cells, we performed the immunofluorescence assay. Our results suggested that CA inhibits the G9a expression (Supplementary Fig. 2). To validate G9a and ATF4 binding on Beclin-1 and LC3B proximal promoter in CA-treated GC cells, we performed the ChIP assay from DNA fragments by sonication. In the real-time ChIP assay, the binding sites associated with Beclin-1 and LC3B genes were bound by G9a before CA treatment in NCI-N87 and MKN-74 cells, respectively, and CA treatment inhibited G9a binding and induced ATF4 binding on Beclin-1 and LC3B promoter (Fig. 7a–c). To determine if G9a is associated with CA-mediated autophagic cell death, after NCI-N87 and MKN-74 cells were knocked down by G9a-specific siRNA, CA treatment was performed. In addition, when we performed cell viability analysis, the LDH assay, and Western blotting analysis, cell viability was more decreased by CA in G9a knockdown cells than in control cells, and LDH release was more increased in CA-treated G9a knockdown cells than in control cells (Fig. 7d). Western blotting analysis revealed that G9a knockdown cells had upregulated LC3-II expression, and CA treatment also blocked G9a levels and increased LC3-II levels (Fig. 7e). To investigate whether co-treatment with CA and BIX-01294 is associated with autophagic cell death in CA-treated NCI-N87 and MKN-74 cells, we performed the cell viability assay, the LDH assay, and Western blotting analysis. Cell viability was significantly decreased by CA or BIX-01294 treatment, and LDH cytotoxicity was increased after CA or BIX-01294 treatment; however, CA + BIX-01294 showed further decreased cell viability and enhanced LDH release in NCI-N87 and MKN-74 cells (Fig. 7f). Furthermore, the synergic effects of CA+BIX-01294 on cell viability and LDH release were reversed in 3-MA-pretreated NCI-N87 and MKN-74 cells (Fig. 7f). Western blotting suggested that CA + BIX-01294 downregulated the G9a expression and upregulated the LC3B-II level in NCI-N87 and MKN-74 cells (Fig. 7g). In addition, 3-MA inhibited the reduction of G9a and the increase of LC3-II in CA- and/or BIX-01294-treated NCI-N87 and MKN-74 cells (Fig. 7g). In conclusion, these results indicate that CA + BIX-01294 treatment induces autophagic cell death by inhibiting G9a, whereas autophagy inhibition suppresses CA + BIX-01294-induced autophagic cell death through the restoration of G9a. Therefore, our findings suggest that G9a is essential for CA-induced autophagic cell death in GC cells.
Discussion
Many researchers have suggested that flavonoids, including kaempferol, apigenin, and quercetin, can be used as potential anti-cancer drugs owing to their potent anti-tumor effect and lesser side effects [48,49,50]. Although flavonoids are one of many studied phytochemicals, detailed biological experiments have encouraged to diverse disease therapeutics. Previous reports against the role of cinnamaldehyde, a flavonoid isolated from C. cassia, can be a novel anti-cancer drug, but there is a lack of knowledge about detailed biological and molecular mechanisms of CA. Cinnamaldehyde, a well-known HDAC inhibitor and anti-tumor reagent, exerts powerful anti-cancer effect through apoptosis and cell death in various cancer types, including colorectal cancer, non-small cell lung cancer, head and neck cancer, hepatocarcinoma, and leukemia [51, 52]. Programmed cell death type II (Autophagic cell death) was reported to have differential mechanism and signaling programmed cell death type I (Apoptosis) [53]. Unlike apoptosis, autophagic cell death induces cell death by producing ROS, losing plasma membrane integrity, and membrane oxidation degradation and then mediates cell death via the activation of many caspases, including caspase−2, −3, −6, 8, 9, and 10 [54, 55]. Furthermore, Bcl family proteins such as Bcl-2 and Bcl-Xl play a potential role to determine differential mechanism between apoptosis and autophagic cell death [56]. Bcl-2 blocks apoptosis process by inhibiting the activation of Bax and the release of cytochrome c [57]. Bcl-2 on the endoplasmic reticulum (ER) suppresses autophagy process by interacting with beclin-1 and activates autophagy process by dissociating with beclin-1 [58]. Recent reports suggested that apoptosis machinery regulates autophagy process; however, autophagy-related proteins also modulate apoptosis process [59]. In this work, we show the first evidence that CA causes autophagy and cell death via the PERK–CHOP axis of ER stress pathways and the G9a binding on Beclin-1 and LC3B promoter in GC. Cinnamomum cassia extract (CCE) could suppress human oral cancer cell growth via caspase‐3 cleavage, Bcl‐2 reduction, and increasing autophagic markers, including LC3A, autophagy‐related protein 14, Rubicon and p62 in vivo and in vitro. However, autophagy inhibition increases apoptosis and cell death in CCE-treated human oral cancer cells, indicating that CCE induces protective autophagy and apoptosis [60]. Furthermore, 2’-hydroxycinnamaldehyde (HCA) also induces apoptosis and protective autophagy in human head and neck cancer cells [61]. However, we demonstrated that CA mediates autophagy and cell death by stimulating cleavage caspase-3; phosphorylating AMPKα, LC3B, Beclin-1, and ATG5; and downregulating p62 and mTOR phosphorylation in GC cells.
ER stress triggers diverse cell death-related pathways, such as intracellular Ca2+, MEKK1, ER membrane re-organization, and programmed cell death type II (autophagic cell death), in various cancer types [62,63,64,65]. Prolonged and excessive stimuli by flavonoids causes ER stress to initiate the apoptosis and autophagic cell death pathway [66]. PERK–eIF2α–ATF4–CHOP and IRE1–JNK/XBP1–CHOP signaling pathways are the two useful signposts of ER stress, which is regulated by ROS and calcium production [67]. Therefore, ER stress has been suggested as a potential strategy for diseases therapy. Recently, an emerging study has reported the use of phytochemicals, such as phenolic acids, stilbenes, tannins, coumarins, and flavonoids targeting ER stress, which have an anti-cancer effect [68]. Morusin, a flavonoid isolated in the root bark of Morus australis (Moraceae), has been suggested to activate ER stress-mediated cell death by enhancing GRP78, IRE1α, and CHOP as well as phosphorylation of eIF2α and Ca2+ ion production in epithelial ovarian cancer cells [69]. Baicalein causes ER stress-induced cell death in hepatocellular carcinoma cells. It upregulated the expression of IRE1α, CHOP and GRP78 and the phosphorylation of PERK, JNK and eIF2α through calcium release, suggesting that it mediates ER stress [70]. HCA, the selective hydrogenation of CA, upregulated the glucose-regulated protein 78 (GRP78), GADD153, heme oxygenase-1 (HMOX1), homocysteine-responsive ER-resident ubiquitin-like domain member 1 protein (HERPUD1), Bax, and cytochrome c in several human cancer cells, indicating that HCA induces ER stress-mediated cell death via ROS release [71]. We found that CA has shown significant anti-cancer activity and triggers cell death via the PERK–CHOP axis in GC cells. CA exerts the phosphorylation of PERK and eIF2α and the accumulation of ATF4 and CHOP in a dose- and time-dependent manner. Thapsigargin (TG), an ER stress inducer to raise the intracellular calcium levels, mediates higher cell death in CA-treated GC cells compared to cells treated with TG or CA alone. In addition, targeting ER stress, including PERK- and CHOP-specific siRNAs, inhibited CA-induced cell death. Herein, our results indicated that CA increased intracellular Ca2+ release and cell death through ER stress.
Hot topics in increasing reports indicate a biological mechanistic interplay between the ER stress and autophagy [72]. Both LC3B and p62 interact with each other and are central factors of the autophagosome for the autophagy process [73]. Recent reports suggested that inducing ATF4 in the ER stress pathway frequently induces autophagic cell death by binding with a cyclic AMP response element site on the proximal promoter of autophagy-related genes, including LC3B, ATG5, and p62 [74]. Euchromatic histone–lysine N-methyltransferase (G9a) has been studied to serve functional roles in cell differentiation and tumor growth, and G9a was found to be upregulated under hypoxia response [75]. Furthermore, G9a binds to the promoters of autophagy-related genes, such as LC3B, Beclin-1, HIF-1, and WIPI1, and its binding inhibits the autophagy process [76]. In the relationship among ER stress, autophagy, and G9a, we hypothesize that G9a may act as an activator by binding at Beclin-1 and LC3B promoter and that ATF4 binding may block G9a binding at LC3B promoter. HDAC inhibitor often exerts the downregulation of G9a via epigenetic modification, and both HDAC and G9a inhibitors mediate autophagic cell death [77]. BIX01294, a G9a inhibitor, induces autophagic cell death by dissociating G9a binding at LC3B promoter in colon cancer cells [78]. Our previous reports indicated that kaempferol, an inhibitor of HDAC and a flavonoid, mediates ER stress and autophagic cell death by inhibiting G9a binding at LC3 promoter in GC cells [79]. These findings suggested that CA induces ER stress and autophagic cell death by inhibiting G9a binding at LC3B promoter in GC cells.
Conclusion
In conclusion, our results identified that CA mediates ER stress and autophagic cell death via the PERK–CHOP signaling pathway, inhibition of G9a binding on Beclin-1 and LC3B promoter, and dissociation of Bcl-2–Beclin-1 in GC cells. A broader study of the biological mechanism of CA may suggest useful anti-cancer therapeutic strategies.
References
Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, et al. Cinnamomum cassia Presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules. 2019;24:pii: E3473.
Nagai H, Shimazawa T, Matsuura N, Koda A. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action. Jpn J Pharmacol. 1982;32:813–22.
Youn HS, Lee JK, Choi YJ, Saitoh SI, Miyake K, Hwang DH, et al. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol. 2008;75:494–2.
Schoene NW, Kelly MA, Polansky MM, Anderson RA. Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Lett. 2005;230:134–40.
Khan A, Safdar M, Ali MM, Khan, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215–8.
Hong SH, Ismail IA, Kang SM, Han DC, Kwon BM. Cinnamaldehydes in cancer chemotherapy. Phytother Res. 2016;30:754–67.
Attoub S, Hassan SAH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, et al. Petroianu, Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol. 2011;651:18–25.
Bishayee K, Khuda-Bukhsh AR, Huh SO. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol Cells. 2015;38:518–27.
Wheatley NC, Andrews KT, Tran TL, Lucke AJ, Reid RC, Fairlie DP. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components. Bioorg Med Chem Lett. 2010;20:7080–4.
Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3:166–79.
Kim DH, Kim M, Kwon HJ. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol. 2003;36:110–9.
Menbari MN, Rahimi K, Ahmadi A, Elyasi A, Darvishi N, Hosseini V, et al. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression. Life Sci 2019;237:116945.
Füllgrabe J, Hajji N, Joseph B. Cracking the death code: apoptosis-related histone modifications. Cell Death Differ. 2010;17:1238–43.
Simó-Riudalbas L, Esteller M. Targeting the histone orthography of cancer: drugs for writers, erasers and readers. Br J Pharmacol. 2015;172:2716–32.
Rao VK, Ow JR, Shankar SR, Bharathy N, Manikandan J, Wang Y, et al. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation. Nucleic Acids Res. 2016;44:8129–43.
Li F, Zeng J, Gao Y, Guan Z, Ma Z, Shi Q, et al. G9a inhibition induces autophagic cell death via AMPK/mTOR pathway in bladder transitional cell carcinoma. PLoS ONE. 2015;10:e0138390.
de Narvajas AAM, Gomez TS, Zhang JS, Mann AO, Taoda Y, Gorman JA, et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol. 2013;33:3983–93.
Weng X, Cheng X, Xu XH. Sin3B mediates collagen type I gene repression by interferon gamma in vascular smooth muscle cells. Biochem Biophys Res Commun. 2014;447:263–70.
Peixoto P, Grandvallet C, Feugeas JP, Guittaut M, Hervouet E. Epigenetic control of autophagy in cancer cells: a key process for cancer-related phenotypes. Cells. 2019;8:1656.
Kim Y, Kim YS, Kim DE, Lee JS, Song JH, Kim HG, et al. BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy. 2013;9:2126–39.
Yin C, Ke X, Hou RJ, Dong Z, Wang F, Zhang K, et al. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating Mtor. FASEB J 2019;33:14036–50.
Ren A, Qiu Y, Cui H, Fu G. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma. Biochem Biophys Res Commun. 2015;459:10–7.
Ron D, Harding HP. Protein-folding homeostasis in the endoplasmic reticulum and nutritional regulation. Cold Spring Harb Perspect Biol. 2012;4:pii:a013177.
Kim I, Reed WJC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008;7:1013–30.
Sovolyova N, Healy S, Samali A, Logue SE. Stressed to death-mechanisms of ER stress-induced cell death. Biol Chem. 2014;395:1–13.
Deniaud A, el dein OS, Maillier E, Poncet D, Kroemer G, Lemaire C, et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene. 2008;27:285–99.
Rutkowski DT, Hegde RS. Regulation of basal cellular physiology by the homeostatic unfolded protein response. J Cell Biol. 2010;189:783–94.
Kohno K, Normington K, Sambrook J, Gething MJ, Mori K. The promoter region of the yeast KAR2 (BiP) gene contains a regulatory domain that responds to the presence of unfolded proteins in the endoplasmic reticulum. Mol Cell Biol. 1993;13:877–90.
Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell. 2017;168:692–706.
Iurlaro R, Muñoz-Pinedo C. Cell death induced by endoplasmic reticulum stress. FEBS J. 2016;283:2640–52.
Verfaillie T, Salazar M, Velasco G, Agostinis P, Linking ER. Stress to autophagy: potential implications for cancer therapy. Int J Cell Biol. 2010;2010:930509.
Rzymski T, Milani M, Singleton DC, Harris AL. Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia. Cell Cycle. 2009;8:3838–47.
Rzymski T, Milani M, Pike L, Buffa F, Mellor HR, Winchester L, et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene. 2010;29:4424–35.
Prieto-Dominquez N, Garcia-Mediavilla MV, Sanchez-Campos S, Mauriz JL, Gonzalez-Gallego J. Autophagy as a molecular target of flavonoids underlying their protective effects in human disease. Curr Med Chem. 2018;25:814–38.
Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861–73.
Singh SS, Vats S, Chia AY, Tan TZ, Deng S, Ong MS, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142–58.
Zhou B, Lu Q, Liu J, Fan L, Wang Y, Wei W, et al. Melatonin increases the sensitivity of hepatocellular carcinoma to sorafenib through the PERK-ATF4-Beclin1 pathway. Int J Biol Sci. 2018;15:1905–20.
Erlich S, Mizrachy L, Segev O, Lindenboim L, Zmira O, Adi-Harel S, et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy. 2007;3:561–8.
Sujobert P, Poulain L, Paubelle E, Zylbersztejn F, Grenier A, Lambert M, et al. Co-activation of AMPK and mTORC1 Induces cytotoxicity in acute myeloid leukemia. Cell Rep. 2015;11:1446–57.
Rouschop KMA, Beucken TVD, Dubois L, Bussink HJ, Savelkouls K, Keulers T, et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest. 2010;120:127–41.
Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells. 2012;1:284–2.
Egan DF, Chun MG, Vamos M, Zou H, Rong J, Miller CJ, et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59:285–97.
Bahar E, Kim H, Yoon HER. Stress-mediated signaling: action potential and Ca2+ as key players. Int J Mol Sci. 2016;17:1558.
Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol. 2000;2:326–32.
Füllgrabe J, Heldring N, Hermanson O, Joseph B. Cracking the survival code: autophagy-related histone modifications. Autophagy. 2014;10:556–61.
Patil M, Choudhari AS, Pandita S, Islam MA, Raina P, Kaul-Ghanekar R. Cinnamaldehyde, cinnamic acid, and cinnamyl alcohol, the bioactives of Cinnamomum cassia exhibit HDAC8 inhibitory activity: an in vitro and in silico study. Pharmacogn Mag 2017;13:S645–51.
Chen TQ, Hu N, Huo B, Masau JF, Yi X, Zhong XX, et al. EHMT2/G9a inhibits aortic smooth muscle cell death by suppressing autophagy activation. Int J Biol Sci. 2020;16:1252–63.
Imran M, Salehi B, Sharifi-Rad J, Gondal TA, Saeed, Imran A, et al. Kaempferol: a key emphasis to its anticancer potential. Molecules. 2019;24:pii: E2277.
Zhang L, Cheng X, Gao Y, Zheng J, Xu Q, Sun Y, et al. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct 2015;6:3464–72.
Ezzati M, Yousefi B, Velaei K, Safa A. A review on anti-cancer properties of quercetin in breast cancer. Life Sci. 2020;248:117463.
Tian F, Yu CT, Ye WD, Wang Q. Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer. Biochem Biophys Res Commun. 2017;493:1260–6.
Lin LT, Wu SJ, Lin CC. The anticancer properties and apoptosis-inducing mechanisms of cinnamaldehyde and the herbal prescription Huang-Lian-Jie-Du-Tang (Huáng Lián Jiě Dú Tang) in human hepatoma cells. J Tradit Complement Med. 2013;3:227–33.
Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891–906.
Tsapras P, Nezis IP. Caspase involvement in autophagy. Cell Death Differ. 2017;24:1369–79.
Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis. 2008;13:1–9.
Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell. 2005;122:927–39.
Adams JM. Ways of dying:multiple pathways to apoptosis. Genes Dev. 2003;17:2481–95.
Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin1. Nature. 1999;402:672–6.
Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–52.
Yu CH, Chu SC, Yang SF, Hsieh YS, Lee CY, Chen PN. Induction of apoptotic but not autophagic cell death by Cinnamomum cassia extracts on human oral cancer cells. J Cell Physiol. 2019;234:5289–303.
Ahn SG, Jin YH, Yoon JH, Kim SA. The anticancer mechanism of 2’-hydroxycinnamaldehyde in human head and neck cancer cells. Int J Oncol. 2015;47:1793–800.
Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998;280:1763–6.
Kang MJ, Chung J, Ryoo HD. CDK5 and MEKK1 mediate pro-apoptotic signaling following endoplasmic reticulum stress in an autosomal dominant retinitis pigmentosa model. Nat cell Biol. 2012;14:409–15.
Varadarajan S, Bampton ET, Smalley JL, Tanaka K, Caves RE, Butterworth M, et al. A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. Cell Death Differ. 2012;19:1896–907.
Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 2006;26:9220–31.
Guo H, Lin W, Zhang X, Zhang X, Hu Z, Li L, et al. Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway. Oncotarget. 2017;8:82207–16.
Guo W, Ding J, Zhang A, Dai W, Liu S, Diao Z, et al. The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells. Int J Mol Sci. 2014;15:484–3.
Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612.
Xue J, Li R, Zhao X, Ma C, Lv X, Liu L, et al. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer. Chem Biol Interact. 2018;283:59–4.
Wang Z, Jiang C, Chen W, Zhang G, Luo D, Cao Y, et al. Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells. Biomed Res Int. 2014;2014:732516.
Hong SH, Kim J, Kim JM, Lee SY, Shin DS, Son KH, et al. Apoptosis induction of 2’-hydroxycinnamaldehyde as a proteasome inhibitor is associated with ER stress and mitochondrial perturbation in cancer cells. Biochem Pharmacol. 2007;74:557–65.
Cai Y, Arikkath J, Yang L, Guo ML, Periyasamy P, Buch S. Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy. 2016;12:225–44.
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131–45.
Xiao Y, Deng Y, Yuan F, Xia T, Liu H, Li Z, et al. ATF4/ATG5 signaling in hypothalamic proopiomelanocortin neurons regulates fat mass via affecting energy expenditure. Diabetes. 2017;66:1146–58.
Ke XX, Zhang D, Zhu S, Xia Q, Xiang Z, Cui H. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS ONE. 2014;9:e106962.
Ahmad F, Dixit D, Joshi SD, Sen E. G9a inhibition induced PKM2 regulates autophagic responses. Int J Biochem Cell Biol. 2016;78:87–5.
Wu LP, Wang X, Li L, Zhao Y, Lu S, Yu Y, et al. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol. 2008;28:3219–35.
Fan JD, Lei PJ, Zheng JY, Wang X, Li S, Liu H, et al. The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death. PLoS ONE. 2015;10:e0116782.
Kim TW, Lee SY, Kim M, Cheon C, Ko SG. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells. Cell Death Dis. 2018;9:875.
Acknowledgements
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2018R1D1A1B07048556).
Author information
Authors and Affiliations
Contributions
TWK designed and performed most experiments. TWK also discussed the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kim, T.W. Cinnamaldehyde induces autophagy-mediated cell death through ER stress and epigenetic modification in gastric cancer cells. Acta Pharmacol Sin 43, 712–723 (2022). https://doi.org/10.1038/s41401-021-00672-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-021-00672-x
- Springer Nature Singapore Pte Ltd.
Keywords
This article is cited by
-
Cinnamaldehyde inhibits the NLRP3 inflammasome by preserving mitochondrial integrity and augmenting autophagy in Shigella sonnei-infected macrophages
Journal of Inflammation (2024)
-
Cinnamaldehyde ameliorates STZ-induced diabetes through modulation of autophagic process in adipocyte and hepatic tissues on rats
Scientific Reports (2024)
-
Cinnamaldehyde Regulates the Migration and Apoptosis of Gastric Cancer Cells by Inhibiting the Jak2/Stat3 Pathway
Digestive Diseases and Sciences (2024)
-
Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms
Future Journal of Pharmaceutical Sciences (2023)
-
In vitro antiviral effect of cinnamon oil, Moringa oleifera extract, Manuka honey, and Nigella sativa oil against SARS-CoV-2 compared to remdesivir
Bulletin of the National Research Centre (2023)